Recent News for BMRA - Biomerica, Inc.

Date	Title
Sep 9	Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Aug 31	Biomerica Full Year 2024 Earnings: US$0.35 loss per share (vs US$0.50 loss in FY 2023)
Aug 29	Biomerica reports FY results
Aug 29	Biomerica Reports Fiscal 2024 Year End Results
Jul 1	Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers